Neoadjuvant Therapy for Stage II-IVA Resectable Esophageal Squamous Cell
Conditions: Neoadjuvent; PD-1 Inhibitor; Chemotherapy; Esophageal Squamous Cell Carcinoma Intervention: Drug: Pembrolizumab, Albumin Paclitaxel, 5-fluorouracil, Cisplatin Sponsor: Tang-Du Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials